Available IPD datapackage for study 'A Phase 3, Randomized, Active-controlled Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13vPnC Vaccine Compared With a 7vPnC in Healthy Infants in China'

This study is primarily designed to evaluate the IgG immune responses to the 13 pneumococcal
serotypes induced by 13vPnC compared with the immune responses induced by 7vPnC when measured
1 month after the infant series, and to evaluate the acceptability of the safety profile of
13vPnC as measured by the incidence rates of local reactions, systemic events and adverse
events.